Skip to main content
. 2002 Dec 7;325(7376):1348–1351. doi: 10.1136/bmj.325.7376.1348

Figure.

Figure

Glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes: patients undergoing percutaneous coronary intervention and patients not undergoing percutaneous coronary intervention. Results show odds ratio (95% confidence interval) for death or myocardial infarction (CABG=coronary artery bypass graft surgery, PCI=percutaneous coronary intervention)